rs143208937
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_172105.4(EYA4):c.1814G>A(p.Arg605Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000144 in 1,613,650 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_172105.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000235 AC: 59AN: 251024Hom.: 0 AF XY: 0.000280 AC XY: 38AN XY: 135652
GnomAD4 exome AF: 0.000141 AC: 206AN: 1461342Hom.: 0 Cov.: 32 AF XY: 0.000147 AC XY: 107AN XY: 726970
GnomAD4 genome AF: 0.000177 AC: 27AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74474
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Arg605Gln var iant in EYA4 has been identified by our laboratory in two individuals with heari ng loss. However, in one of these individuals, an alternate genetic etiology of the hearing loss was identified. It was also identified in an unaffected parent. This variant has been identified in 14/18840 East Asian chromosomes by the Geno me Aggregation Database (gnomAD, http://http://gnomad.broadinstitute.org; dbSNP rs143208937). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational analy sis do not provide strong evidence for or against an impact to the protein. In s ummary, while the clinical significance of the p.Arg605Gln variant is uncertain, available data suggest that it is more likely to be benign. ACMG/AMP Criteria a pplied: BP5. -
Dilated cardiomyopathy 1J Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Autosomal dominant nonsyndromic hearing loss 10 Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at